EXHIBIT 10.27 Portions of this exhibit were omitted and filed separately with the Secretary of the Commission pursuant to an application for confidential treatment filed with the Commission pursuant to Rule 24b-2 under the Securities Exchange Act of...Purchase Agreement • May 11th, 2000 • Viropharma Inc • Pharmaceutical preparations • New York
Exhibit 10.30 VIROPHARMA INCORPORATED STOCK OPTION PLAN NON-QUALIFIED STOCK OPTION AGREEMENT ViroPharma Incorporated (the "Company") hereby grants to Robert J. Glaser (the "Optionee") an option to purchase a total of 20,000 shares of Common Stock of...Non-Qualified Stock Option Agreement • November 13th, 1998 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
andRights Agreement • September 21st, 1998 • Viropharma Inc • Pharmaceutical preparations • Delaware
Exhibit 10.1 SETTLEMENT AGREEMENT AND RELEASE THIS SETTLEMENT AGREEMENT AND RELEASE (this "Settlement Agreement") is made this August 1, 2002, by and among VIROPHARMA INCORPORATED, a Delaware corporation ("ViroPharma"), VCO INCORPORATED, a Delaware...Settlement Agreement • August 1st, 2002 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
Exhibit 10.20 FIRST AMENDMENT TO AGREEMENT This FIRST AMENDMENT TO AGREEMENT (this "Amendment") is made this 21st day of February, 1997, between ViroPharma Incorporated (formerly ViroPharma, Inc.), a Delaware corporation ("VP"), having its principal...Agreement • June 25th, 1997 • Viropharma Inc • Pharmaceutical preparations
EXHIBIT 1 2,250,000 Shares VIROPHARMA INCORPORATED COMMON STOCK UNDERWRITING AGREEMENT ---------------------- November __, 1996 COWEN & COMPANY J.P. MORGAN SECURITIES INC. As Representatives of the several Underwriters c/o Cowen & Company Financial...Underwriting Agreement • November 8th, 1996 • Viropharma Inc • Pharmaceutical preparations • New York
W I T N E S E T H: - - - - - - - - -Consulting Agreement • November 12th, 1997 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
To Summit Bank as Trustee INDENTURE Dated as of March 1, 2000Indenture • May 11th, 2000 • Viropharma Inc • Pharmaceutical preparations • New York
EXHIBIT 1.1Underwriting Agreement • October 19th, 1999 • Viropharma Inc • Pharmaceutical preparations • New York
BETWEENLease Agreement • November 13th, 2001 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
Exhibit 10.30 VIROPHARMA INCORPORATED RESTRICTED STOCK AGREEMENT THIS RESTRICTED STOCK AGREEMENT dated as of August 21, 2000 is made by and between ViroPharma Incorporated (the "Company"), and Michel de Rosen (the "Executive"). 1. Restricted Shares....Restricted Stock Agreement • November 13th, 2000 • Viropharma Inc • Pharmaceutical preparations
EXHIBIT 4.2 AMENDMENT NO. 1 TO RIGHTS AGREEMENT ----------------------------------- AMENDMENT, dated as of May 5, 1999, to the Rights Agreement, dated as of September 10, 1996 (the "Rights Agreement"), between ViroPharma Incorporated, a Delaware...Rights Agreement • May 14th, 1999 • Viropharma Inc • Pharmaceutical preparations
Section of Trust Indenture Act Section of of 1939, as amended Indenture Indenture ----------------------------- --------- 310(a).............................................. 7.09 310(b).............................................. 7.08...Indenture • September 12th, 2001 • Viropharma Inc • Pharmaceutical preparations • New York
AMONGInvestment Agreement • May 14th, 1999 • Viropharma Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT dated as of September 9, 2011 among VIROPHARMA INCORPORATED, as Borrower The Lenders Party Hereto JPMORGAN CHASE BANK, N.A. as Administrative Agent and BMO HARRIS FINANCING INC., TD BANK, N.A. and MORGAN STANLEY BANK, N.A. as...Credit Agreement • October 27th, 2011 • Viropharma Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT (this “Agreement”) dated as of September 9, 2011 among VIROPHARMA INCORPORATED, the LENDERS from time to time party hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent and BMO HARRIS FINANCING INC., TD BANK, N.A. and MORGAN STANLEY BANK, N.A.,, as Co-Syndication Agents.
WITNESSETH ----------Licensing Agreement • May 11th, 2001 • Viropharma Inc • Pharmaceutical preparations • New York
DEVELOPMENT AGREEMENT --------------------- This Agreement is entered into this 16th day of April, 1997, by and between SELOC AG, a corporation organized under the laws of Switzerland with a principal place of business at Industriestrasse 7, 4410...Development Agreement • June 25th, 1997 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
Exhibit 1.2 4,000,000 Shares VIROPHARMA INCORPORATED COMMON STOCK, $.002 PAR VALUE UNDERWRITING AGREEMENT November 14, 2001Underwriting Agreement • November 15th, 2001 • Viropharma Inc • Pharmaceutical preparations • New York
AMENDMENT TO RESTRICTED STOCK PURCHASE AGREEMENT Amendment to Restricted Stock Purchase Agreement dated as of January 17, 1996, among VIROPHARMA, INC., a Delaware corporation (the "Corporation"), and Frank Baldino, Jr. (the "Purchaser"), dated as of...Restricted Stock Purchase Agreement • November 8th, 1996 • Viropharma Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.29 PROMISSORY NOTE ---------------Promissory Note • November 12th, 1997 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
Exhibit 1.1 UNDERWRITING AGREEMENT VIROPHARMA INCORPORATED 2,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • July 11th, 1997 • Viropharma Inc • Pharmaceutical preparations • New York
W I T N E S E T H: - - - - - - - - - WHEREAS, the Company desires to engage Consultant to provide services to the Company in accordance with the terms and conditions set forth herein; andConsulting Agreement • November 12th, 1997 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
ViroPharma Incorporated $225,000,000 2.00% Convertible Senior Notes Due 2017Underwriting Agreement • March 26th, 2007 • Viropharma Inc • Pharmaceutical preparations • New York
ViroPharma Incorporated, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of $225,000,000 principal amount of the 2.00% Convertible Senior Notes due 2017, convertible into shares of Common Stock, par value $0.002 per share (the “Stock”) of the Company specified above (the “Firm Securities”) and, at the election of the Underwriters, up to an aggregate of $25,000,000 additional aggregate principal amount of such Convertible Senior Notes (the “Optional Securities”) (the Firm Securities and the Optional Securities which the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”).
RECITALSStock Purchase Agreement • May 11th, 2001 • Viropharma Inc • Pharmaceutical preparations • Delaware
RECITALSStock Purchase Agreement • March 15th, 2000 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
Exhibit 10.33 Portions of this exhibit were omitted and filed separately with the Secretary of the Commission pursuant to an application for confidential treatment filed with the Commission pursuant to Rule 24b-2 under the Securities Exchange Act of...Collaboration and License Agreement • August 14th, 2003 • Viropharma Inc • Pharmaceutical preparations • New Jersey
Agreement --------- 1. Defined Terms. Capitalized terms not otherwise defined herein ------------- shall have the meaning set forth in the Lease.Purchase Option Agreement • July 22nd, 1997 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
EXHIBIT 10.7 COLLABORATIVE RESEARCH AGREEMENT * THIS COLLABORATIVE RESEARCH AGREEMENT is made as of the 23rd day of July 1996, between BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., a Delaware corporation having offices at 900 Ridgebury Road, Ridgefield,...Collaborative Research Agreement • November 14th, 1996 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
RECITALS --------Stock Purchase Agreement • November 13th, 2001 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
1.2 Cashless Exercise. At any time after a Change of Control ----------------- (as defined herein) but prior to the Expiration Date, in lieu of the payment of the Exercise Price, the Warrantholder shall have the right (but not the obligation) to...Common Stock Purchase Warrant • May 14th, 1999 • Viropharma Inc • Pharmaceutical preparations • New York
Exhibit 10.28 REGISTRATION RIGHTS AGREEMENT by and among VIROPHARMA INCORPORATEDRegistration Rights Agreement • May 11th, 2000 • Viropharma Inc • Pharmaceutical preparations • New York
6. RELATIONSHIP BETWEEN PARTIES. Consultant will be retained by the Company ---------------------------- strictly for the purposes and to the extent set forth in this Agreement and his relationship to the Company shall be that of an independent...Consulting Agreement • March 27th, 1998 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
WITNESSETH: -----------Employee Stock Purchase Agreement • November 8th, 1996 • Viropharma Inc • Pharmaceutical preparations • Delaware
CHANGE OF CONTROL AGREEMENTChange of Control Agreement • January 7th, 2011 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
THIS CHANGE OF CONTROL AGREEMENT (this “Agreement”), is made on this 6th day of January, 2010, by and between VIROPHARMA INCORPORATED (the “Company”) and (the “Employee”).
Underwriting AgreementUnderwriting Agreement • December 7th, 2005 • Viropharma Inc • Pharmaceutical preparations • New York
